The Cut Down, Annoyed, Guilty, Eye-Opener (CAGE) was designed to screen patient risk for alcohol abuse and dependence in the clinical setting. This version of the tool is a brief… Read More
In January 2019, Dr. Joseph Goldberg and Dr. John Meyers presented a webinar entitled, “The Art Of Clinical Assessment In Patients With Bipolar Disorder”. As a follow-up to that webinar,… Read More
The Hamilton Depression Rating Scale (HAM-D; HRSD; HDRS), designed in 1960, has become one of the most widely utilized rating scales intended to assess depression disorder symptom severity and change.… Read More
In this short presentation, hear from Fatima Sadat, PharmD, as she reviews different types of digital technology that may provide tools for the assessment or management of mental health treatment.… Read More
Individuals living with mental health diagnoses are often marginalized by society, and stigmatization and discrimination may form a barrier to their recovery and social integration. There are a lot of… Read More
Throughout May each year, we celebrate Mental Health Awareness Month (MHAM). For 2019, Mental Health America (MHA) is celebrating 70 years of celebrating MHAM by sharing their MHAM Toolkit. They… Read More
Glutamate is the predominant excitatory neurotransmitter in the nervous system, and glutamatergic dysregulation has been implicated in the pathophysiology of both mood disorders and schizophrenia. In this webinar, Dr. James… Read More
This summary was developed utilizing the full recorded presentation of this webinar. You can access the full sourcing, polling results, recording, or presentation slides here: https://psychu.org/the-role-of-glutamate-in-mood-disorders-schizophrenia/. On March 19, 2019,… Read More
Background & Purpose One of the barriers to helping individuals living with major depressive disorder (MDD) reach recovery is that depression often goes undiagnosed and untreated. A variety of symptoms… Read More